137 related articles for article (PubMed ID: 8104537)
1. Targeting of an activated T-cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD26.
Duke-Cohan JS; Morimoto C; Schlossman SF
Blood; 1993 Oct; 82(7):2224-34. PubMed ID: 8104537
[TBL] [Abstract][Full Text] [Related]
2. Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29.
Duke-Cohan JS; Morimoto C; Schlossman SF
Transplantation; 1993 Nov; 56(5):1188-96. PubMed ID: 7504344
[TBL] [Abstract][Full Text] [Related]
3. Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2.
Nishimura T; Nakamura Y; Takeuchi Y; Gao XH; Tokuda Y; Okumura K; Habu S
Jpn J Cancer Res; 1991 Nov; 82(11):1207-10. PubMed ID: 1836455
[TBL] [Abstract][Full Text] [Related]
4. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD6-blocked ricin: an anti-pan T-cell immunotoxin.
Collinson AR; Lambert JM; Liu Y; O'Dea C; Shah SA; Rasmussen RA; Goldmacher VS
Int J Immunopharmacol; 1994 Jan; 16(1):37-49. PubMed ID: 8150554
[TBL] [Abstract][Full Text] [Related]
6. Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function.
Rasmussen RA; Counts SL; Lambert JM; Collinson AR
Cancer Immunol Immunother; 1992; 35(5):355-63. PubMed ID: 1394340
[TBL] [Abstract][Full Text] [Related]
7. Cell-type-specific cytotoxicity of anti-CD4 and anti-CD8 ricin immunotoxins against human alloreactive T-cell clones.
Uckun FM; Myers DE; Ledbetter JA; Wee SL; Vallera DA
Blood; 1989 Nov; 74(7):2445-54. PubMed ID: 2572287
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and study of cytotoxic properties of the immunotoxin anti-CD7/A-chain of ricin].
Tonevitskiĭ AG; Ershova GV; Agapov II; Toptygin AIu; Korotkova OV; Shereshkov SN; Kadagidze ZG; Baryshnikov AIu
Dokl Akad Nauk SSSR; 1991; 317(3):749-53. PubMed ID: 1720085
[No Abstract] [Full Text] [Related]
9. Antibody binding profile of purified and cell-bound CD26. Designation of BT5/9 and TA5.9 to the CD26 cluster.
de Meester I; Scharpé S; Vanham G; Bosmans E; Heyligen H; Vanhoof G; Corte G
Immunobiology; 1993 Jun; 188(1-2):145-58. PubMed ID: 8104877
[TBL] [Abstract][Full Text] [Related]
10. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
Tutt A; Stevenson GT; Glennie MJ
J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655
[TBL] [Abstract][Full Text] [Related]
11. Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.
Press OW; Martin PJ; Thorpe PE; Vitetta ES
J Immunol; 1988 Dec; 141(12):4410-7. PubMed ID: 2461993
[TBL] [Abstract][Full Text] [Related]
12. [Selective cytotoxic effect of an immunotoxin on human erythroid tumor cells].
Tonevitskiĭ AG; Agapov II; Mechetner EB
Mol Biol (Mosk); 1991; 25(5):1181-7. PubMed ID: 1753950
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.
Vanham G; Kestens L; De Meester I; Vingerhoets J; Penne G; Vanhoof G; Scharpé S; Heyligen H; Bosmans E; Ceuppens JL
J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):749-57. PubMed ID: 8099610
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes.
Mattern T; Scholz W; Feller AC; Flad HD; Ulmer AJ
Scand J Immunol; 1991 Jun; 33(6):737-48. PubMed ID: 1675482
[TBL] [Abstract][Full Text] [Related]
16. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism.
Vojdani A; Pangborn JB; Vojdani E; Cooper EL
Int J Immunopathol Pharmacol; 2003; 16(3):189-99. PubMed ID: 14611720
[TBL] [Abstract][Full Text] [Related]
17. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
Shen GL; Li JL; Vitetta ES
J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic potency of CD22-ricin A depends on intracellular routing rather than on the number of internalized molecules.
van Horssen PJ; van Oosterhout YV; de Witte T; Preijers FW
Scand J Immunol; 1995 Jun; 41(6):563-9. PubMed ID: 7770726
[TBL] [Abstract][Full Text] [Related]
19. On the role of CD26 in CD4 memory T cells.
Cordero OJ; Yang CP; Bell EB
Immunobiology; 2007; 212(2):85-94. PubMed ID: 17336829
[TBL] [Abstract][Full Text] [Related]
20. Increased protein kinase C activity in human memory T cells.
Höllsberg P; Melinek J; Benjamin D; Hafler DA
Cell Immunol; 1993 Jun; 149(1):170-9. PubMed ID: 8099849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
